PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsGene knock-out creates diabetes-free, mighty mice

BioNews

Gene knock-out creates diabetes-free, mighty mice

Published 10 January 2013 posted in News and appears in BioNews 633

Author

George Frodsham

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

Mice that don't produce a certain protein in their fat cells do not develop type 2 diabetes despite an increase in weight, scientists report. In a separate study, the same research group also managed to double the physical performance of mice by removing the same protein from their muscle cells...

Mice that don't produce a certain protein in their fat cells do not develop type 2 diabetes despite an increase in weight, scientists report. In a separate study, the same research group also managed to double the physical performance of mice by removing the same protein from their muscle cells. In both studies, the team used a virus to knock out the gene coding for the protein in the relevant tissue.

In the first study, the researchers prevented production of the protein NCoR1 in the mice's fat cells. The mice had no resistance to insulin which would normally mean they would go on to develop type 2 diabetes. The knock-out mice also weighed 15 percent more than the control animals.

'The specimens that became obese via this treatment did not suffer from diabetes, unlike mice who become obese for other reasons', said author Professor Johan Auwerx of the Ecole Polytechnique Fédérale de Lausanne in Switzerland.

In the second study, the mice which had NCoR1 removed from their muscle cells were able to run 1,600 metres in two hours, versus the 800 metres run in the same time by untreated mice. 'Effectively, the mice go further, faster, on the same amount of gas', remarked Professor Auwerx.

The research may help to develop new methods of preventing or treating diabetes; it could also help to slow the degeneration of muscles in the elderly. 'In addition, we think that this could be used as a basis for developing a treatment for genetic muscular dystrophy', said Professor Auwerx.

NCoR1 normally has a role in controlling and limiting muscle growth. Without the protein, mitochondria — the energy-generating 'batteries' that power cells — can work for long periods at full speed.

Although it appears that the protein limits physical performance, Professor Auwerx cautioned against people attempting to use the discovery to improve their own physical capabilities. He told New Scientist: 'We only know what happens if it's knocked out either in fat or muscle, and it could have serious side effects on other organs'.

NCoR1 is also essential for fetal development, although its specific function has not been identified.

Related Articles

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
13 January 2014 • 1 minute read

Two genes pinpointed as cause of diabetes in babies

by Dr Shanya Sivakumaran

Scientists have identified mutations in two genes that cause neonatal diabetes, a rare condition affecting around 1 in 100,000 births...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
3 January 2014 • 2 minutes read

Diabetes gene traced back to Neanderthals

by Dr Charlotte Warren-Gash

A gene variant increases the risk of type 2 diabetes in Latin American populations, according to a study in Nature...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
15 November 2013 • 2 minutes read

Gene therapy could reverse lethal muscle-wasting disease

by Ruth Pidsley

A team of researchers based at Ohio State University, USA, have used gene therapy to restore nerve and muscle function and prolong life in mice with a form of spinal muscular atrophy (SMA), a lethal childhood muscle-wasting disorder. Results from the study, published in the journal Nature Biotechnology, were so encouraging that the researchers hope to progress to human trials within two years...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
21 March 2013 • 2 minutes read

Ten new gene links bolster understanding of type 2 diabetes

by Zara Mahmoud

A large-scale statistical analysis of DNA from nearly 150,000 people of European descent has identified ten new regions of DNA that may help us understand the biological processes linked to glucose metabolism and insulin production in type 2 diabetes....

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
23 January 2013 • 1 minute read

Disappointing results one year into diabetes stem cell trial

by Marianne Kennedy

Biotech company Osiris Therapeutics has this month released an optimistic update on its Phase II trial evaluating the use of adult stem cells for the treatment of type 1 diabetes, despite lacking positive results...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
14 November 2012 • 2 minutes read

Scientists discover new way to reverse genetic defects

by Rebecca Hill

Scientists have discovered a way to bypass the type of mutation that causes about a third of human genetic diseases. Experiments in yeast have shown how chemical modifications can allow a cell's machinery to ignore mistakes in DNA known as nonsense mutations...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
9 June 2009 • 2 minutes read

Human speech gene gives mice a deeper squeak

by Dr Will Fletcher

Transgenic mice containing a human speech gene could give clues about the evolution of language. A team from the Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany, replaced the mouse gene FOXP2 with the human equivalent - a gene implicated in speech problems, and thought to be linked...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« UK Supreme Court upholds gene patent

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

15 August 2022 • 2 minutes read

Call to end ban on HIV-positive partner gamete 'donation'

15 August 2022 • 2 minutes read

Melanoma invades new tissues using nerve cell gene

15 August 2022 • 2 minutes read

Exceeding alcohol limits could damage DNA and accelerate ageing

15 August 2022 • 2 minutes read

Blood cell gene mutations affect mitochondria, increasing cardiovascular disease risk

15 August 2022 • 2 minutes read

Jumping gene helps immune system fight viruses

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856